In the News

Healthcare professionals, advocates, and families impacted by diabetes say the cost to treat diabetes in Oregon continues to increase.

According to a study by Quote Wizard, Oregon diabetics have the eighth highest average annual medical expenses in the nation.

In a July health care poll, Oregonians indicated more trust in their Salem legislators than Congress. Simultaneously, Congress now contemplates giving our state exactly the freedom needed to create our own health care plan.

The U.S. Senate Commerce, Science, and Transportation Committee advanced key legislation to address the growing global marine debris crisis late last week.

Two lawmakers from Oregon are looking into how much people with diabetes pay for the insulin they need.

Sen. Jeff Merkley introduced the End Price Gouging for Insulin Act following a report prepared for fellow Democratic Rep. Suzanne Bonamici found that people in the region pay about $1,000 more a year on insulin than people in other countries — a "rip-off" according to Merkley.

A new rule in Oregon prohibits U.S. Immigration and Customs Enforcement from detaining people at state courthouses without a judicial arrest warrant.

The rule also protects people going to or from court proceedings from being stopped in nearby entryways, sidewalks and parking lots.

Sen. Jeff Merkley introduced legislation to end "exorbitant price hikes" on insulin.

The End Price Gouging for Insulin Act comes as a new report highlights the high cost of insulin in Northwest Oregon.

Over 80 members of the House of Representatives have now called on White House senior adviser Stephen Miller to resign after leaked emails published this week showed his affinity for white nationalism.

HuffPost contacted the office of every House member and asked whether Miller should resign. All told, over 80 representatives, all Democrats, have said he should.

A pair of Democratic lawmakers called on the National Academy of Sciences to review EPA's proposed science transparency rule over concerns it would inhibit the agency's ability to protect Americans' health and the environment by limiting the scope of research EPA could consider.